Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001640334-21-000487
Filing Date
2021-03-02
Accepted
2021-03-01 21:05:16
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 embi_424b3.htm 424B3 1161259
2 embi_424b3img2.jpg GRAPHIC 3835
  Complete submission text file 0001640334-21-000487.txt   1167944
Mailing Address 5910 PACIFIC CENTER BLVD, SUITE 320 SAN DIEGO CA 92121
Business Address 5910 PACIFIC CENTER BLVD, SUITE 320 SAN DIEGO CA 92121 (949) 480-9051
Skye Bioscience, Inc. (Filer) CIK: 0001516551 (see all company filings)

EIN.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-223895 | Film No.: 21700868
SIC: 2834 Pharmaceutical Preparations